Want to join the conversation?
During 3Q15 among its four business segments, $TMO delivered revenues of $1.08Bil (up 0.9% YoverY) in Life Sciences Solutions, $779MM (down 0.9% YoverY) in Analytical Instruments, $777MM (down 4.3% YoverY) in Specialty Diagnostics and $1.64Bil (down 0.6% YoverY) in Laboratory Products & Services respectively.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.